Carbon footprint of atrial fibrillation catheter ablation.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
16 02 2023
Historique:
received: 03 06 2022
accepted: 08 08 2022
pubmed: 16 9 2022
medline: 22 2 2023
entrez: 15 9 2022
Statut: ppublish

Résumé

Climate change represents the biggest global health threat of the 21st century. Health care system is itself a large contributor to greenhouse gas (GHG) emissions. In cardiology, atrial fibrillation (AF) catheter ablation is an increasing activity using numerous non-reusable materials that could contribute to GHG emission. Determining a detailed carbon footprint analysis of an AF catheter ablation procedure allows the identification of the main polluting sources that give opportunities for reduction of environmental impact. To assess the carbon footprint of AF catheter ablation procedure. To determine priority actions to decrease pollution. An eco-audit method used to predict the GHG emission of an AF catheter ablation procedure was investigated. Two workstations were considered including surgery and anaesthesia. In the operating room, every waste produced by single-use medical devices, pharmaceutical drugs, and energy consumption during intervention were evaluated. All analyses were limited to the operating room. Thirty procedures were analysed over a period of 8 weeks: 18 pulmonary veins isolation RF ablations, 7 complex RF procedures including PVI, roof and mitral isthmus lines, ethanol infusion of the Marshall vein and cavo tricuspid isthmus line, and 5 pulmonary vein isolation with cryoballoon. The mean emission during AF catheter ablation procedures was 76.9 kg of carbon dioxide equivalent (CO2-e). The operating field accounted for 75.4% of the carbon footprint, while only 24.6% for the anaesthesia workstation. On one hand, material production and manufacturing were the most polluting phases of product life cycle which, respectively, represented 71.3% (54.8 kg of CO2-e) and 17.0% (13.1 kg of CO2-e) of total pollution. On the other hand, transport contributed in 10.6% (8.1 kg of CO2-e), while product use resulted in 1.1% (0.9 kg of CO2-e) of GHG production. Electrophysiology catheters were demonstrated to be the main contributors of environmental impact with 29.9 kg of CO2-e (i.e. 38.8%). Three dimensional mapping system and electrocardiogram patches were accounting for 6.8 kg of CO2-e (i.e. 8.8% of total). AF catheter ablation involves a mean of 76.9 kg of CO2-e. With an estimated 600 000 annual worldwide procedures, the environmental impact of AF catheter ablation activity is estimated equal to 125 tons of CO2 emission each day. It represents an equivalent of 700 000 km of car ride every day. Electrophysiology catheters and patches are the main contributors of the carbon footprint. The focus must be on reducing, reusing, and recycling these items to limit the impact of AF ablation on the environment. A road map of steps to implement in different time frames is proposed.

Identifiants

pubmed: 36107465
pii: 6701534
doi: 10.1093/europace/euac160
pmc: PMC10103577
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-340

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Références

BMC Public Health. 2019 Apr 30;19(1):461
pubmed: 31039773
Europace. 2022 Sep 1;24(8):1300-1306
pubmed: 35943366
Lancet. 2019 Nov 16;394(10211):1836-1878
pubmed: 31733928
Health Aff (Millwood). 2020 Dec;39(12):2088-2097
pubmed: 33284689
Environ Sci Technol. 2015 Feb 3;49(3):1779-86
pubmed: 25517602
Environ Health Perspect. 2021 Jul;129(7):76001
pubmed: 34251875
Int J Life Cycle Assess. 2020;25(10):1930-1941
pubmed: 32863598
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Eye (Lond). 2013 Apr;27(4):495-501
pubmed: 23429413
Eur J Cardiothorac Surg. 2021 Dec 1;60(6):1325-1331
pubmed: 34411226

Auteurs

Geoffroy Ditac (G)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.

Pierre-Jean Cottinet (PJ)

INSA-Lyon, LGEF, Université de Lyon, 20 Av. Albert Einstein, 69100 Villeurbanne, France.

Minh Quyen Le (M)

INSA-Lyon, LGEF, Université de Lyon, 20 Av. Albert Einstein, 69100 Villeurbanne, France.

Daniel Grinberg (D)

Department of Cardiac Surgery, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.
Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, 8 avenue Rockefeller, 69003 Lyon, France.

Josselin Duchateau (J)

Department of electrophysiology, CHU Bordeaux, Université de Bordeaux, IHU LIRYC, Av. du Haut Lévêque, 33600 Pessac, France.

Kévin Gardey (K)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.

Arnaud Dulac (A)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.

Antoine Delinière (A)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.
Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, 8 avenue Rockefeller, 69003 Lyon, France.

Christelle Haddad (C)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.

Julie Boussuge-Roze (J)

Department of electrophysiology, CHU Bordeaux, Université de Bordeaux, IHU LIRYC, Av. du Haut Lévêque, 33600 Pessac, France.

Frédéric Sacher (F)

Department of electrophysiology, CHU Bordeaux, Université de Bordeaux, IHU LIRYC, Av. du Haut Lévêque, 33600 Pessac, France.

Pierre Jaïs (P)

Department of electrophysiology, CHU Bordeaux, Université de Bordeaux, IHU LIRYC, Av. du Haut Lévêque, 33600 Pessac, France.

Philippe Chevalier (P)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.
Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, 8 avenue Rockefeller, 69003 Lyon, France.

Francis Bessière (F)

Department of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, 69500 Bron, France.
Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, 8 avenue Rockefeller, 69003 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH